drugset / Trial / NCT01571518

Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy

NCT01571518

RandomizedParallel-groupOpen-labelPrevention

Summary

After resection of lymph node positive breast cancer, the injection duration and timing of Granulocyte-colony stimulating factor (G-CSF) could affect the neutropenia with TAC (Taxotere, Adriamycin, cyclophosphamide) chemotherapy.

Timeline

Start
2012-04
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject filgrastim Protein / enzyme biologic 5 ug/kg

Indications